amiodarone has been researched along with Infant, Newborn, Diseases in 5 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Infant, Newborn, Diseases: Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts.
Excerpt | Relevance | Reference |
---|---|---|
"Background Amiodarone is an iodine-rich medication used to treat maternal and fetal arrhythmias, with known effects on thyroid hormone homeostasis." | 7.91 | Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy. ( Huang, V; Wolf, RM, 2019) |
"Background Amiodarone is an iodine-rich medication used to treat maternal and fetal arrhythmias, with known effects on thyroid hormone homeostasis." | 3.91 | Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy. ( Huang, V; Wolf, RM, 2019) |
" Finally, high dosage of amiodarone (10 mg/kgbw/d) led to continuous control of the heart rate without tachycardic episodes." | 1.43 | [Perinatal Presentation and Complicated Course of a Multifocal Atrial Tachycardia]. ( Braun, M; Schirrmeister, J; Siauw, C; Wirbelauer, J, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, V | 1 |
Wolf, RM | 1 |
Viveiros, E | 1 |
Aveiro, AC | 1 |
Costa, E | 1 |
Nunes, JL | 1 |
Braun, M | 1 |
Siauw, C | 1 |
Schirrmeister, J | 1 |
Wirbelauer, J | 1 |
Wiegand, G | 1 |
Haber, HP | 1 |
Binder, G | 1 |
Kaulitz, R | 1 |
Hofbeck, M | 1 |
Widerhorn, J | 1 |
Bhandari, AK | 1 |
Bughi, S | 1 |
Rahimtoola, SH | 1 |
Elkayam, U | 1 |
1 review available for amiodarone and Infant, Newborn, Diseases
Article | Year |
---|---|
Fetal and neonatal adverse effects profile of amiodarone treatment during pregnancy.
Topics: Adult; Amiodarone; Female; Fetal Diseases; Humans; Infant, Newborn; Infant, Newborn, Diseases; Infan | 1991 |
4 other studies available for amiodarone and Infant, Newborn, Diseases
Article | Year |
---|---|
Transient neonatal hypothyroidism following a short course of maternal amiodarone therapy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Female; Humans; Hypothyroidism; Infant, Ne | 2019 |
Cardiogenic shock in a neonate.
Topics: Amiodarone; Anti-Arrhythmia Agents; Humans; Infant, Newborn; Infant, Newborn, Diseases; Male; Shock, | 2013 |
[Perinatal Presentation and Complicated Course of a Multifocal Atrial Tachycardia].
Topics: Amiodarone; Anti-Arrhythmia Agents; Diagnosis, Differential; Humans; Infant, Newborn; Infant, Newbor | 2016 |
Tital page - ultrasound findings in newborns with amiodarone-induced hypothyroidism.
Topics: Amiodarone; Anti-Arrhythmia Agents; Follow-Up Studies; Humans; Hypothyroidism; Infant, Newborn; Infa | 2009 |